What We Do
The obstacles to providing the best products to the best suited patient are many. Let our Center help you find the way to success.
The Center for Value-Based Medicine® is a preeminent professional health care consulting and research organization focused on value, comparative effectiveness and patient access.
We develop unique information systems, customized approaches and novel strategies that identify and compare the value of pharmaceuticals, devices, and other medical interventions.
The information systems can be used to quantify the effects of disabilities associated with pain and suffering.
Let us help you climb to success. We can; we will.
News & Events
Based on the strength of data, Veklury (remdesivir) has become the standard of care for the treatment of COVID-19 in hospitalized patients. Remdesivir can speed up recovery time and lesson rates of progression to mechanical ventilation while providing critical hope to loved ones and healthcare providers. http://www.gilead.com
CDC updates guidelines for close contacts; emphasizes importance of mask usage, social distancing and hand washing. www.CDC.gov
Evidence-Based to Value-Based Medicine is the Center for Value-Based Medicine text with a foreword by Thomas Scully, former Administrator of the Centers for Medicare and Medicaid Services. Published by the AMA Press, the book is due for an update in the near future. Listed below are several of the comments related to Evidence-Based to Value-Based Medicine and Value-Based […]
Cost-Utility Analysis: 27,000,000 Possible Input Variants. Gary C. Brown, MD, MBA, Melissa M. Brown, MD, MN, MBA, Peter Kertes, MD. Evidence-Based Ophthalmology 2012;12:52-7. Comparative effectiveness is defined by the US Congressional Budget Office  as ‘‘rigorous evaluation of the impact of different options that are available for treating a given medical condition for a particular set of […]
Actuaries from the CMS (Centers for Medicare and Medicaid Services) noted that healthcare spending in the United States in 1960 was $27.5 billion, 5.0% of the $543 billion Gross Domestic Product (GDP). By 2016, total healthcare spending was $3.3 trillion, $10,348 per person and 17.9% of the Gross domestic product. by 2026, the national health expenditure […]